The DOI matches its Crossref record; 1 of the 2 references it cites were found in a registry or an index.
Report on psychoactive drug use among adolescents using ayahuasca within a religious context.
Open accessAbstract
Ritual use of ayahuasca within the context of the Brazilian ayahuasca churches often starts during late childhood or early adolescence. Premature access to psychoactive drugs may represent a risk factor for drug misuse. Conversely, religious affiliation seems to play a protective role in terms of substance abuse. The objective of this study was to describe patterns of drug use in a sample of adolescents using ayahuasca within a religious setting. Forty-one adolescents from a Brazilian ayahuasca sect were compared with 43 adolescents who never drank ayahuasca. No significant differences were identified in terms of lifetime substance consumption. Throughout the previous year period, ayahuasca adolescents used less alcohol (46.31%) than the comparison group (74.4%). Recent use of alcohol was also more frequent among the latter group (65.1%) than among ayahuasca drinkers (32.5%). Although not statistically significant, slight differences in terms of patterns of drug use were definitely observed among groups. Despite their early exposure to a hallucinogenic substance, adolescents using ayahuasca in a controlled setting were mostly comparable to controls except for a considerably smaller proportion of alcohol users. Religious affiliation may have played a central role as a possible protective factor for alcohol use. Thus, ayahuasca seems to be a relatively safe substance as far as drug misuse is concerned.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cross-sectional and longitudinal case-control studies showed that ritual and religious ayahuasca users present fewer alcohol-related problems than control groups and that illicit drug use diminished after joining ayahuasca churches (Grob et al., 1996; Doering-Silveira et al., 2005; Halpern et al., 2008; Fábregas et al., 2010).”
From The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization (2016) · cites this paper as Doering-Silveira et al., 2005
Citations
Cites
Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.
GROB, C. S., McKENNA, D. J., CALLAWAY, J. C., BRITO, G. S., NEVES, E. S., OBERLAENDER, G., SAIDE, O. L., LABIGALINI, E., TACLA, C., MIRANDA, C. T., et al. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199602000-00004 · Cited by 338
Self-citation
Research works printed but not linked: 4
- Dobkin de Rios M., 1994, Yearbook of Ethnomedicine, 3, 113
- Grob C. S., 1999, Ayahuasca; Hallucinogens, Consciousness, and the Spirit of Nature.
- Hesselbrock M. N., 1999, Addictions.
- McKenna D. J., 1998, Heffter Review of Psychedelic Research, 1, 65
Cited by
Sorted by citations
Psychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., Kalin, N. H., McDonald, W. M., & and the Work Group on Biomarkers and Novel Treatments, A. D. O. T. A. P. A. C. O. R. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19010035 · Cited by 649
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.010 · Cited by 506
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Schlag, A. K., Aday, J. S., Salam, I., Neill, J. C., & Nutt, D. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069100 · Cited by 359
dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316638008 · Cited by 306
Psychedelic therapy for smoking cessation: qualitative analysis of participant accounts
Noorani, T., Garcia-Romeu, A., Swift, T. C., Griffiths, R. R., & Johnson, M. W. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118780612 · Cited by 285
The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization
Frecska, E., Bokor, P., & Winkelman, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00035 · Cited by 242
Ayahuasca: pharmacology, neuroscience and therapeutic potential
Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., de la Fuente Revenga, M., Friedlander, P., Feilding, A., & Riba, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.002 · Cited by 226
Classic hallucinogens in the treatment of addictions
Bogenschutz, M. P., & Johnson, M. W. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.002 · Cited by 226
Clinical applications of hallucinogens: a review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201
Kettner, H., Rosas, F. E., Timmermann, C., Kärtner, L., Carhart-Harris, R. L., & Roseman, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.623985 · Cited by 221
Hamill, J., Hallak, J. E. C., Dursun, S. M., & Baker, G. B. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180125095902 · Cited by 201
A Systematic Review of Recent Literature on Religiosity and Substance Use
Chitwood, D. D., Weiss, M. L., & Leukefeld, C. G. (2008) · Journal of Drug Issues · doi:10.1177/002204260803800302 · Cited by 189
Loizaga-Velder, A. K., & Verres, R. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.873157 · Cited by 157
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
Dakic, V., Minardi Nascimento, J., Costa Sartore, R., Maciel, R. D. M., de Araujo, D. B., Ribeiro, S., Martins-de-Souza, D., & Rehen, S. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-12779-5 · Cited by 134
Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment
Brierley, D. I., & Davidson, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.001 · Cited by 138
dos Santos, R. G., Balthazar, F. M., Bouso, J. C., & Hallak, J. E. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116652578 · Cited by 125
Bogenschutz, M. P., & Pommy, J. M. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1376 · Cited by 130
Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT)
Cameron, L. P., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00101 · Cited by 128
Health status of ayahuasca users
Barbosa, P. C. R., Mizumoto, S., Bogenschutz, M. P., & Strassman, R. J. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1383 · Cited by 112
Barbosa, P. C. R., Cazorla, I. M., Giglio, J. S., & Strassman, R. J. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10400530 · Cited by 108
A religiosidade, a espiritualidade e o consumo de drogas
Sanchez, Z. M., & Nappo, S. A. (2007) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832007000700010 · Cited by 111
Ayahuasca’s entwined efficacy: An ethnographic study of ritual healing from ‘addiction’
Talin, P., & Sanabria, E. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.02.017 · Cited by 103
Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism
Bogenschutz, M. P., & Forcehimes, A. A. (2016) · Journal of Humanistic Psychology · doi:10.1177/0022167816673493 · Cited by 102
Experiences of encounters with Ayahuasca–“the vine of the soul”
Kjellgren, A., Eriksson, A., & Norlander, T. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10399767 · Cited by 97
Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca
Barbosa, P. C. R., Tófoli, L. F., Bogenschutz, M. P., Hoy, R. V., Berro, L. F., Marinho, E. A. V., Areco, K. C. N., & Winkelman, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00136 · Cited by 97
Nunes, A. A., SANTOS, R. G. D., Osório, F. D. L., Sanches, R. F., Crippa, J. A. S., & Hallak, J. E. C. (2016) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2016.1188225 · Cited by 95
Oliveira-Lima, A. J., Santos, R., Hollais, A. W., Gerardi-Junior, C. A., Baldaia, M. A., Wuo-Silva, R., Yokoyama, T. S., Costa, J. L., Malpezzi-Marinho, E. L. A., Ribeiro-Barbosa, P. C., et al. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.01.032 · Cited by 91
Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology
SANTOS, R. G. D. (2013) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.763564 · Cited by 94
Therapeutic Applications of Classic Hallucinogens
Bogenschutz, M. P., & Ross, S. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_464 · Cited by 92
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 92
Lawn, W., Hallak, J. E. C., Crippa, J. A. S., SANTOS, R. G. D., Porffy, L., Barratt, M. J., Ferris, J., WINSTOCK, A. R., & Morgan, C. J. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-14700-6 · Cited by 83
Ayahuasca in Adolescence: A Neuropsychological Assessment
Doering-Silveira, E., López, E., Grob, C. S., de Ríos, M. D., Alonso, L. K., Tacla, C., Shirakawa, I., Bertolucci, P. H. F., & da Silveira, D. X. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399791 · Cited by 72
Self-citationDimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users
Cakic, V., Potkonyak, J., & Marshall, A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.015 · Cited by 72
Changes in Spirituality Among Ayahuasca Ceremony Novice Participants
Trichter, S., Klimo, J., & Krippner, S. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10399905 · Cited by 79
Mans, K., Kettner, H., Erritzøe, D., Haijen, E. C. H. M., Kaelen, M., & Carhart-Harris, R. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.647909 · Cited by 63
Mendes, F. R., Costa, C. D. S., Wiltenburg, V. D., Morales-Lima, G., Fernandes, J. A. B., & Filev, R. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100025 · Cited by 67
Ayahuasca: Uses, Phytochemical and Biological Activities
Estrella-Parra, E. A., Almanza-Pérez, J. C., & Alarcón-Aguilar, F. J. (2019) · Natural Products and Bioprospecting · doi:10.1007/s13659-019-0210-5 · Cited by 61
Perkins, D., Pagni, B. A., Sarris, J. J., Barbosa, P. C. R., & Chenhall, R. D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.884703 · Cited by 63
Perkins, D., Opaleye, E. S., Šimonová, H., Bouso, J. C., Tófoli, L. F., Coelho, N. L. G., Schubert, V., & Sarris, J. J. (2021) · Drug and Alcohol Review · doi:10.1111/dar.13348 · Cited by 54
Serotonergic Hallucinogens and Emerging Targets for Addiction Pharmacotherapies
Ross, S. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.04.002 · Cited by 54
Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies
Calleja‐Conde, J., Morales-Garcia, J. A., Echeverry‐Alzate, V., Bühler, K., Giné, E., & López‐Moreno, J. A. (2022) · Addiction Biology · doi:10.1111/adb.13229 · Cited by 58
Cata-Preta, E. G., Serra, Y. A., Moreira-Junior, E. D. C., Reis, H. S., Kisaki, N. D., Libarino-Santos, M., Silva, R. R. R., Barros-Santos, T., Santos, L. C., Barbosa, P. C. R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00561 · Cited by 53
Ayahuasca: A review of historical, pharmacological, and therapeutic aspects
Ruffell, S., Crosland‐Wood, M., Palmer, R., Netzband, N., Tsang, W., Weiss, B., Gandy, S., Cowley‐Court, T., Halman, A., McHerron, D., et al. (2023) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.146 · Cited by 61
Rodrigues, L. S., Rossi, G. N., Rocha, J. M., Osório, F. D. L., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01267-7 · Cited by 47
Ayahuasca's therapeutic potential: What we know – and what not
Maia, L. O., Daldegan‐Bueno, D., Wießner, I., de Araújo, D. B., & Tófoli, L. F. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.10.008 · Cited by 54
Morgan, C. J. A., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.10.009 · Cited by 42
Koslowski, M., Johnson, M. W., Gründer, G., & Betzler, F. (2021) · Current Addiction Reports · doi:10.1007/s40429-021-00401-8 · Cited by 42
Ayahuasca and the Treatment of Drug Addiction
Bouso, J. C., & Riba, J. (2013) · Springer eBooks · doi:10.1007/978-3-642-40426-9_6 · Cited by 42
Is Ayahuasca an Option for the Treatment of Crack Cocaine Dependence?
da Cruz, J. I., & Nappo, S. A. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1447174 · Cited by 36
Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation
Johnson, M. W. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_327 · Cited by 37
Labate, B. C. (2011) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2011.566498 · Cited by 33
Ayahuasca and cancer treatment
Schenberg, E. E. (2013) · SAGE Open Medicine · doi:10.1177/2050312113508389 · Cited by 33
Dimethyltryptamine: Endogenous Role and Therapeutic Potential
Rodrigues, A. V., Almeida, F., & Vieira‐Coelho, M. A. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1602291 · Cited by 34
AYAHUASCA BEYOND THE AMAZON THE BENEFITS AND RISKS OF A SPREADING TRADITION
Trichter, S. (2010) · The Journal of transpersonal psychology · Cited by 29
Anderson, B. T., Labate, B. C., Meyer, M. J., Tupper, K. W., Barbosa, P. C. R., Grob, C. S., Dawson, A., & McKenna, D. J. (2012) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2012.02.007 · Cited by 32
Self-citationAyahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?
Malcolm, B., & Lee, K. C. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.01.039 · Cited by 34
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy
Orsolini, L., Chiappini, S., Papanti, D., Latini, R., Volpe, U., Fornaro, M., Tomasetti, C., Vellante, F., & Berardis, D. D. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2728 · Cited by 33
Tófoli, L. F., & de Araújo, D. B. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.06.005 · Cited by 35
Personality Traits in Former Spanish Substance Users Recovered with Ayahuasca
Apud Peláez, I. E. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1752960 · Cited by 22
Psychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodríguez, C. I., Kalin, N. H., & McDonald, W. M. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.19104 · Cited by 28
Psychedelics in the Treatment of Substance Use Disorders and Addictive Behaviors: A Scoping Review
Richard, J., & Garcia‐Romeu, A. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00629-8 · Cited by 22
The current state of ayahuasca research in animal models: A systematic review
Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110738 · Cited by 21
Politi, M., Friso, F., & Mabit, J. (2018) · Cultura y Droga · doi:10.17151/culdr.2018.23.26.6 · Cited by 19
Hogea, L., Tabugan, D. C., Costea, I., Albai, O., Nussbaum, L. A., Cojocaru, A., Corsaro, L., & Anghel, T. (2025) · Medicina · doi:10.3390/medicina61020278 · Cited by 19
Soremekun, R. O., Omole, O. E., Adeyemi, O. C., & Oshatimi, A. M. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06232 · Cited by 18
Basedow, L. A., Riemer, T., Reiche, S., Kreutz, R. H., & Majić, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739966 · Cited by 17
Paradoxes of ayahuasca expansion: The UDV–DEA agreement and the limits of freedom of religion
Labate, B. C. (2011) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2011.606397 · Cited by 15
Apud, I., Scuro, J., Carrera, I., & Oliveri, A. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2053004 · Cited by 14
Psychedelics: From Cave Art to 21st-Century Medicine for Addiction
Vamvakopoulou, I. A., & Nutt, D. J. (2024) · European Addiction Research · doi:10.1159/000540062 · Cited by 18
Ayahuasca: uma revisão dos aspectos farmacológicos e toxicológicos
Pires, A. P. S., de Oliveira, C. D. R., & Yonamine, M. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 14
The enchanted snake and the forbidden fruit: the ayahuasca ‘fairy tale’ tourist
Dean, A. K. (2019) · Journal of Marketing Management · doi:10.1080/0267257x.2019.1601635 · Cited by 13
[Religion and brain functioning (part 2): does religion have a positive impact on mental health?].
Kornreich, C., & Aubin, H. (2012) · PubMed · Cited by 8
Hilal, F. F., Jeanblanc, J., Deschamps, C., Naassïla, M., Pierrefiche, O., & Hamida, S. B. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02757-3 · Cited by 8
Exploring the therapeutic potential of psychedelics in treating substance use disorders
Li, Y., Li, H., Wang, H., & Wang, X. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03168-w · Cited by 6
Psychedelics and substance use disorder treatment
DuPont, C. M., & Johnson, M. W. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.005 · Cited by 8
A perspective on psychedelic teratogenicity: the utility of zebrafish models
Syed, O. A., Tsang, B., Petranker, R., & Gerlai, R. T. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.08.001 · Cited by 7
AYAHUASCA: neuroquímica e farmacologia
SANTOS, R. G. D. (2007) · SMAD Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português) · doi:10.11606/issn.1806-6976.v3i1p01-11 · Cited by 9
Use of Herbal Medicine to Treat Drug Addiction
Mendes, F. R., & Prado, D. D. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-43172-7_4 · Cited by 6
Recreational use of psychoactive substances among secondary school students in North-Central Nigeria
Omotoso, A. B., Makanjuola, A. B., & Abiodun, O. A. (2020) · Journal of Substance Use · doi:10.1080/14659891.2020.1779361 · Cited by 6
Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action
Miller, E. A., Capone, C., Eaton, E. M., Swift, R. M., & Haass‐Koffler, C. L. (2025) · CNS Drugs · doi:10.1007/s40263-025-01199-z · Cited by 6
Um panorama da literatura sobre a internacionalização das religiões ayahuasqueiras brasileiras
de Assis, G. L., & Labate, B. C. (2017) · Ciências Sociais Unisinos · doi:10.4013/csu.2017.53.2.08 · Cited by 5
Vicentini, A. B., Rodrigues, L. S., Rossi, G. N., Rocha, J. M., Guerra, L. T. L., Reis, J. A. S., Maekawa, R. M., Osório, F. D. L., Bouso, J. C., Santos, F. P., et al. (2023) · Psychoactives · doi:10.3390/psychoactives2040022 · Cited by 4
Mendive, F. M., Giovannetti, C., & Arce, S. G. (2023) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2023.2264466 · Cited by 6
THE EFFECTS OF PARTICIPATION IN AYAHUASCA RITUALS ON GAYS' AND LESBIANS' SELF PERCEPTION
Kennedy, J. F. (2011) · Cited by 4
Substance Abuse: Hallucinogen‐ and MDMA‐Related Disorders
El‐Mallakh, R. S., Halpern, J. H., & Abraham, H. D. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch76 · Cited by 4
The current state of ayahuasca research in animal models: A systematic reviewPreprint
Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2022) · doi:10.31234/osf.io/7s3b8 · Cited by 4
Psychedelics for substance use disorders: are women being addressed? A scoping review
Nigri, A. W., de Arruda, I. F., Maia, C. G. F., Tófoli, L. F., & Carezzato, F. (2025) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2025.104960 · Cited by 3
Longo, C. M., & Musah, R. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8579-1_12 · Cited by 3
Acute and Long-Term Effects of Ayahuasca on (Higher-Order) Cognitive Processes
Mason, N. L., & Kuypers, K. P. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_7 · Cited by 3
Phipps, S. M., & Grundmann, O. (2017) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63930-1.00001-6 · Cited by 3
Halpern, J. H., Suzuki, J., Huertas, P. E., & Passie, T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_54 · Cited by 3
Hallucinogens and Related Compounds
Grob, C. S., & de Ríos, M. D. (2012) · Wiley eBooks · doi:10.1002/9781118340851.ch21 · Cited by 4
Self-citationde Sousa, P. C. M., de Sousa, I. N. A., Leite, L. L. L., Oliveira, A. L. O., Souza, K. A. D. S., Soares, J. D. S., Viana, M. D. R., & do Amaral, M. P. D. M. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.14251 · Cited by 3
Vargas-Pérez, H., Minauro‐Sanmiguel, F., Ting‐A‐Kee, R. A., Grieder, T. E., Méndez‐Díaz, M., Prospero-Garcia, O. E., & van der Kooy, D. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137597 · Cited by 3
The UDV Religion, Science, and Academic Research
Labate, B. C., Melo, R. V., Shepard, G. H., & Cavnar, C. (2013) · Anthropology of Consciousness · doi:10.1111/anoc.12008 · Cited by 2
Do Hallucinogens Have a Role in the Treatment of Addictions? A Review of the Current Literature
Nigam, K. B., & Pandurangi, A. K. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00871-x · Cited by 2
Scuro, J. (2023) · Ciencias Sociales y Religión · doi:10.20396/csr.v25i00.8672228 · Cited by 2
Reconsidering Context in Psychedelic Research: Rituals as Ancient Libraries of Knowledge
Lutz, H. (2023) · Journal of Scientific Exploration · doi:10.31275/20222441 · Cited by 1
Ayahuasca in Western society and the metacognitive counselling approach
Kawakami, A., & Suzuki, M. (2023) · Counselling and Psychotherapy Research · doi:10.1002/capr.12628 · Cited by 1
Politi, M., Friso, F., & Mabit, J. (2018) · Cultura y Droga · Cited by 1
Metadata
- Authors
- Doering-Silveira, E., Grob, C. S., de Rios, M. D., Lopez, E., Alonso, L. K., Tacla, C., & Da Silveira, D. X.
- Affiliations
- Universidade Federal de São Paulo (BR)
- University of California, Los Angeles (US)
- Universidade Católica de Brasília (BR)
- Venue
- Journal of Psychoactive Drugs
- Publisher
- Informa UK Limited
- Published
- 2005-06
- Volume
- 37
- Issue
- 2
- Pages
- 141-144
- ISSN
- 0279-1072 (ISSN-L)
- 2159-9777
- OpenAlex
- W2012159028
- Cited by
- 122
- References
- 2
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 12 · 2020: 4 · 2019: 3 · 2018: 12 · 2017: 6 · 2016: 11 · 2015: 3 · 2014: 2 · 2013: 5 · 2012: 8
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-sa
- Locations
- Journal of Psychoactive Drugs (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- ayahuasca, ritual drug use, adolescents, drug use patterns, alcohol consumption, religious affiliation, protective factors, hallucinogens
- MeSH terms
- Adolescent, Adult, Brazil, Cross-Sectional Studies, Demography, Female, Humans, Male, Plant Extracts, Psychotropic Drugs, Religion, Risk Factors, Time, Chi-Square Distribution, Substance-Related Disorders, Banisteriopsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review